Nakamura Rikuto, Tsumura Ryo, Anzai Takahiro, Asano Ryutaro, Yasunaga Masahiro
Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, 277-8577, Japan.
Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, 277-8562, Japan.
Cancer Immunol Immunother. 2025 Jun 21;74(8):246. doi: 10.1007/s00262-025-04036-w.
T cell-dependent bispecific antibodies (TDBs) are next-generation antibody therapies that link cancer cells and T cells to achieve potent antitumor effects. Despite the successful development of TDBs for hematological malignancies, their efficacy against solid tumors remains limited. Overcoming this challenge requires a deeper understanding of their mechanisms of action. While the basic process of immunological synapse (IS) formation and T cell activation by TDB is known, the detailed effects of IS on the bystander effect and T cell migration, both crucial for therapeutic efficacy, remain unclear. This study investigated these mechanisms using an EGFR/CD3 TDB (hEx3) and EGFR knockout cancer cells (KO). The results revealed that IS formation by TDB induced a bystander effect, leading to damage in surrounding KO, with the extent depending on the proportion of EGFR-positive wild-type cancer cells (WT) and the duration of co-culture. Furthermore, IS formation significantly enhanced T cell cytokine and chemokine secretion, promoting T cell migration. These findings provide critical insights into TDB efficacy mechanisms and highlight the importance of evaluating IS formation in developing new antibody drugs. Establishing a reliable system for assessing IS formation will be essential for advancing TDBs and other antibody-based therapies, particularly against solid tumors.
T细胞依赖性双特异性抗体(TDBs)是新一代抗体疗法,可将癌细胞与T细胞连接起来,以实现强大的抗肿瘤效果。尽管TDBs在血液系统恶性肿瘤的治疗中取得了成功,但它们对实体瘤的疗效仍然有限。克服这一挑战需要更深入地了解其作用机制。虽然TDB诱导免疫突触(IS)形成和T细胞活化的基本过程是已知的,但IS对旁观者效应和T细胞迁移的详细影响(这两者对治疗效果都至关重要)仍不清楚。本研究使用EGFR/CD3 TDB(hEx3)和EGFR基因敲除癌细胞(KO)对这些机制进行了研究。结果显示,TDB诱导的IS形成会引发旁观者效应,导致周围KO细胞受损,其程度取决于EGFR阳性野生型癌细胞(WT)的比例和共培养时间。此外,IS形成显著增强了T细胞细胞因子和趋化因子的分泌,促进了T细胞迁移。这些发现为TDB的疗效机制提供了关键见解,并突出了在开发新抗体药物时评估IS形成的重要性。建立一个可靠的评估IS形成的系统对于推进TDB和其他基于抗体的疗法,尤其是针对实体瘤的疗法至关重要。